Expression of costimulatory molecules B7-1 and B7-2 by macrophages along invasive margin of colon cancer: A possible antitumor immunity?

Laboratory Investigation

Volumn 77, Issue 3, 1997, Pages 231-243

  Ohtani, Haruo ^a   Naito, Yoshitaka ^a   Saito, Kazuya ^a   Nagura, Hiroshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; B7 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; KI 67 ANTIGEN;

ARTICLE; CANCER INVASION; CELL CONTACT; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; LYMPHOCYTIC INFILTRATION; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CELL DIVISION; COLON; COLONIC NEOPLASMS; HUMANS; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON; MICROSCOPY, IMMUNOELECTRON; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REFERENCE VALUES; T-LYMPHOCYTES;

EID: 0030768642     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Burgio VL, Fais S, Boirivant M, Perrone A, and Pallone F (1995). Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 109:1029-1038.
2. Chaux P, Moutet M, Faivre J, Martin F, and Martin M (1996). Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab Invest 74:975-983.
3. Denfeld RW, Dietrich A, Wuttig C, Tanczos E, Weiss JM, Vanscheidt W, Schoepf E, and Simon JC (1995). In situ expression of B7 and CD28 receptor families in human malignant melanoma: Relevance for T-cell-mediated antitumor immunity. Int J Cancer 62:259-265.
4. + T cells: ICAM-1 or B7-1 can costimulate naïve CD4 T cell activation but both are required for optimum response. J Immunol 155:45-57.
5. Folkman J and Klagsbrun M (1993). Angiogenic factors. Science 235:442-447.
6. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, and Carbone DP (1996). Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med 2:1096-1103.
7. Gagliardi MC, Petrillo GD, Salemi S, Boffa L, Longobardi MG, Dellabona P, Casorati G, Tanigaki N, Harris R, and Lanzavecchia A (1995). Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int Immunol 7:1741-1752.
8. Gimmi CD, Morrison BW, Mainprice BA, Gribben JG, Boussiotis VA, Freeman GJ, Park SYL, Watanabe M, Gong JL, Hayes DF, Kufe DW, and Nadler LM (1996). Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nature Med 2:1367-1371.
9. Hara J, Ohtani H, Matsumoto T, Nakamura S, Kitano A, Arakawa T, Nagura H, and Kobayashi K (in press, 1997). Expression of costimulatory molecules B7-1 and B7-2 in macrophages and granulomas of Crohn's disease: Demonstration of cell-to-cell contact to T-lymphocytes. Lab Invest.
10. + cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 177:1791-1796.
11. Harding FA, McArthur JG, Gross JA, Raulet DH, and Allison JP (1992). CD28-mediated signaling co-stimulates murine T-cells and prevent induction of anergy in T-cell clones. Nature 356:607-609.
12. Hathcock KS, Laszlo G, Pucillo C, Linsley P, and Hodes RJ (1994). Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function. J Exp Med 180:631-640.
13. Huang AY, Bruce AT, Pardoll DM, and Levitsky HI (1996). Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J Exp Med 183:769-776.
14. Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, and Levitsky H (1994). Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961-965.
15. Ioannides C and Whiteside T (1993). T cell recognition of human tumors: Implication for molecular immunotherapy of cancer. Clin Immunol Immunopathol 66:91-106.
16. Jass J R, Love SB, and Northover JMA (1987). A new prognostic classification of rectal cancer. Lancet 329:1303-1306.
17. June CH, Bluestone JA, Nadler LM, and Thompson CB (1994). The B7 and CD28 receptor families. Immunol Today 15:321-331.
18. Krummel MF and Allison JP (1996). CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183:2533-2540.
19. Mehta-Damani A, Markowicz S, and Engleman EG (1994). Generation of antigen-specific CD8+ CTLs from naïve precursors. J Immunol 153:996-1003.
20. Melder RJ, Koenig GC, Witer BP, Safabakhsh N, Munn LL, and Jain RK (1996). During angiogenesis, vascular endothelial growth factor and basic fibroblasts growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med 2:992-997.
21. Mizoi T, Ohtani H, Suzuki Y, Shiiba K, Matsuno S, and Nagura H (1995). Intercellular adhesion molecule-1 expression by macrophages in human gastrointestinal carcinoma: Possible roles as host immune/inflammatory reaction. Pathol Int 45: 565-572.
22. Ohtani H, Kuroiwa A, Obinata M, Ooshima A, and Nagura H (1992). Identification of type I collagen producing cells in human gastrointestinal carcinoma by non-radioactive in situ hybridization and immunoelectron microscopy. J Histochem Cytochem 40:1139-1146.
23. Ohtani H, Nagai T, and Nagura H (1995). Similarities of in situ mRNA expression between gelatinase a (MMP-2) and type I procollagen in human gastrointestinal carcinoma: Comparison with granulation tissue reaction. Jpn J Cancer Res 86:833-839.
24. Ohtani H, Nakamura S, Watanabe Y, Mizoi T, Saku T, and Nagura H (1993). Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 68:520-527.
25. + T-lymphocytes. Lab Invest 75:67-76.
26. Strand S, Hofmann WJ, Hug H, Mueller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, and Galle PR (1996). Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: A mechanism of immune evasion? Nature Med 2:1361-1366.
27. Sundstrom JB and Ansari AA (1995). Comparative study of the role of professional versus semiprofessional or nonprofessional antigen presenting cells in the rejection of vascularized organ allograft. Transplant Immunol 3:273-289.
28. Suzuki Y, Ohtani H, Mizoi T, Takeha S, Shiiba K, Matsuno S, and Nagura H (1995). Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction in human colon carcinoma. Jpn J Cancer Res 86:585-593.
29. Takeha S, Fujiyama Y, Bamba T, Sorsa T, Nagura H, and Ohtani H (1997). Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: A novel approach from immune/inflammatory aspect. Jpn J Cancer Res 88:72-81.
30. Vandenberghe P, Delabie J, de Boer M, Wolf-Peeters DC, and Ceuppens JL (1993). In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: An immunohistochemical study. Int Immunol 5:317-321.
31. Walunas TL, Bakker CY, and Bluestone JA (1996). CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 183:2541-2550.
32. + T cells. J Immunol 155:4111-4117.
33. Yokozeki H, Katayama I, Ohki O, Matsunaga T, Watanabe K, Satoh T, Azuma M, Okumura K, and Nishioka K (1996). Functinal CD86 (B7-2/B70) on cultured human Langerhans' cells. J Invest Dermatol 106:147-153.
34. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, and Storkus WJ (1996). Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183:87-97.